--- title: "爵士制药 (JAZZ.US) — 财务报表" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/JAZZ.US/norm.md" symbol: "JAZZ.US" name: "爵士制药" parent: "https://longbridge.com/zh-CN/quote/JAZZ.US.md" datetime: "2026-05-21T08:07:12.174Z" locales: - [en](https://longbridge.com/en/quote/JAZZ.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/JAZZ.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/JAZZ.US/norm.md) --- # 爵士制药 (JAZZ.US) — 财务报表 ## 利润表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 每股收益 | 4.43 | 3.21 | 4.08 | -11.74 | -1.52 | | ROE | 26.49% | 19.66% | 26.24% | -72.93% | -8.95% | | 营业收入 | 1.07B | 1.20B | 1.13B | 1.05B | 897.80M | | 净利润 | 293.10M | 203.45M | 251.41M | -718.47M | -92.50M | | 营业利润 | 251.30M | 324.14M | 251.51M | 218.97M | -26.00M | | 毛利率 | 90.96% | 90.57% | 88.56% | 88.88% | 91.68% | | 净利率 | 27.42% | 16.98% | 22.33% | -68.71% | -10.30% | | 利润含金量 | 61.56% | 89.41% | 52.99% | 246.44% | -6.05% | ## 资产负债表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 资产与负债 | 11.86B | 11.66B | 11.36B | 10.94B | 11.53B | | 权益乘数 | 2.62 | 2.70 | 2.87 | 2.95 | 2.76 | | 每股净资产 | 72.29 | 70.30 | 65.18 | 61.12 | 67.75 | | 资产周转率 | 0.3795 | 0.3606 | 0.3522 | 0.3664 | 0.3556 | | 现金及短投 | 2.87B | 2.44B | 2.05B | 1.67B | 2.57B | | 存货与应收 | 437.50M | 416.96M | 483.11M | 504.99M | 492.78M | | 长期投资 | 258.90M | 258.74M | 250.12M | 248.06M | 228.05M | | 净债务 | 2.54B | 2.99B | 3.38B | 3.76B | 2.85B | ## 现金流量表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 经营现金流 | 408.20M | 362.52M | 474.62M | 88.86M | 429.80M | | 投资现金流 | 123.10M | -372.16M | -327.80M | -641.02M | -169.00M | | 融资现金流 | -78.50M | 75.44M | -10.83M | -124.53M | -813.50M | | 自由现金流 | 411.91M | 335.40M | 508.33M | 88.37M | 442.09M | | 现金流充裕率 | 1484.36% | 1480.93% | 2070.30% | 428.90% | 55.70% | | 举债与偿债 | - | - | - | - | - | | 资本支出 | -19.70M | -16.73M | -15.18M | -12.97M | -13.90M |